@Article{info:doi/10.2196/24667,
author="Teckie, Sewit
and Solomon, Jeffrey
and Kadapa, Karthik
and Sanchez, Keisy
and Orner, David
and Kraus, Dennis
and Kamdar, Dev P
and Pereira, Lucio
and Frank, Douglas
and Diefenbach, Michael",
title="A Mobile Patient-Facing App for Tracking Patient-Reported Outcomes in Head and Neck Cancer Survivors: Single-Arm Feasibility Study",
journal="JMIR Form Res",
year="2021",
month="Mar",
day="19",
volume="5",
number="3",
pages="e24667",
keywords="mHealth; ePROs; head and neck cancer; mobile phone",
abstract="Background: Patients with head and neck cancer (HNC) frequently experience disease-related symptoms and treatment adverse effects that impact their overall quality of life. Cancer-specific mobile health apps for patient-related outcomes allow patients to communicate with their clinicians and proactively track their symptoms, which have been shown to improve clinical management and disease outcomes. Objective: The purpose of this study was to evaluate the feasibility of LogPAL, a novel iPhone-based mobile health app designed to help HNC survivors track and manage their posttreatment symptoms. Methods: Patients who completed curative treatment for HNC in the preceding 24 months were recruited from 2 clinical sites within a single institution. Upon enrollment, participants completed a brief sociodemographic survey, downloaded the app onto their iPhone devices, and were asked to complete a series of biweekly questionnaires (based on the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events) via the app for an 8-week study period. The primary feasibility endpoints included retention (retaining >80{\%} of the enrolled participants for the duration of the study period), adherence (>50{\%} of the participants completing 100{\%} of the questionnaires over the study period), and usability (a mean system usability scale [SUS] score >68). Additional postintervention questions were collected to assess perceived usefulness, acceptance, and overall satisfaction. Results: Between January and October 2019, 38 participants were enrolled in the study. Three participants dropped out, and 3 were classified as nonusers. The remaining 32 (87{\%}) were eligible for analysis. Their mean age was 57.8 (SD 12.3) years (range 24-77 years, 81{\%} [26/32] male). Overall, 375 of 512 (73.2{\%}) questionnaires were completed, with 17 (53{\%}) of the 32 participants adherent. Participant-reported usability was acceptable; the mean SUS score was 71.9 (95{\%} CI 64.3-79.5) with high satisfaction of LogPAL usefulness and likelihood to recommend to other cancer survivors. Conclusions: This single-arm prospective pilot study showed that LogPAL is a feasible, regularly used, accepted app for HNC survivors, justifying a full-scale pilot. Based on the findings from this study, future iterations will aim to improve usability and test intervention efficacy. ",
issn="2561-326X",
doi="10.2196/24667",
url="https://formative.jmir.org/2021/3/e24667",
url="https://doi.org/10.2196/24667",
url="http://www.ncbi.nlm.nih.gov/pubmed/33739291"
}